|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
UBLITUXIMAB |
L04AG14 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
ATOGEPANT |
N02CD07 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
GANAXOLONE |
N03AX27 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
VAMOROLONE |
H02AB18 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
FARICIMAB |
S01LA09 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
SOMATROGON |
H01AC08 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
RIPRETINIB |
L01EX19 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
ASCIMINIB |
L01EA06 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
ARTESUNATE |
P01BE03 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
MITAPIVAT |
B06AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE |
R03AL12 |
IT
|
II
|
22-12-2020 |
EMEA/H/C/005518 |
03-07-2020 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
